Injectable MMP-sensitive alginate hydrogels as hMSC delivery systems.

Hydrogels with the potential to provide minimally invasive cell delivery represent a powerful tool for tissue-regeneration therapies. In this context, entrapped cells should be able to escape the matrix becoming more available to actively participate in the healing process. Here, we analyzed the performance of proteolytically degradable alginate hydrogels as vehicles for human mesenchymal stem cells (hMSC) transplantation. Alginate was modified with the matrix metalloproteinase (MMP)-sensitive peptide Pro-Val-Gly-Leu-Iso-Gly (PVGLIG), which did not promote dendritic cell maturation in vitro, neither free nor conjugated to alginate chains, indicating low immunogenicity. hMSC were entrapped within MMP-sensitive and MMP-insensitive alginate hydrogels, both containing cell-adhesion RGD peptides. Softer (2 wt % alginate) and stiffer (4 wt % alginate) matrices were tested. When embedded in a Matrigel layer, hMSC-laden MMP-sensitive alginate hydrogels promoted more extensive outward cell migration and invasion into the tissue mimic. In vivo, after 4 weeks of subcutaneous implantation in a xenograft mouse model, hMSC-laden MMP-sensitive alginate hydrogels showed higher degradation and host tissue invasion than their MMP-insensitive equivalents. In both cases, softer matrices degraded faster than stiffer ones. The transplanted hMSC were able to produce their own collagenous extracellular matrix, and were located not only inside the hydrogels, but also outside, integrated in the host tissue. In summary, injectable MMP-sensitive alginate hydrogels can act as localized depots of cells and confer protection to transplanted cells while facilitating tissue regeneration.

[1]  P. Neth,et al.  Scientific category: Stem cells in hematology MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines , 2006 .

[2]  H. Ghandehari,et al.  Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer. , 2013, Biomacromolecules.

[3]  M. Barbosa,et al.  Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-forming ability. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[4]  S. Powis,et al.  Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cells , 2008, Arthritis research & therapy.

[5]  Sunil Kumar Bajpai,et al.  Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions , 2004 .

[6]  Dong-An Wang,et al.  Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. , 2010, Advanced drug delivery reviews.

[7]  Antonios G Mikos,et al.  Strategies for controlled delivery of growth factors and cells for bone regeneration. , 2012, Advanced drug delivery reviews.

[8]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[9]  Pedro L Granja,et al.  Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. , 2011, Acta biomaterialia.

[10]  Robert Langer,et al.  Incorporation of a matrix metalloproteinase-sensitive substrate into self-assembling peptides - a model for biofunctional scaffolds. , 2008, Biomaterials.

[11]  J. Babensee.  Interaction of dendritic cells with biomaterials. , 2008, Seminars in immunology.

[12]  Eben Alsberg,et al.  Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue Engineering , 2001, Biotechnology progress.

[13]  Mark W. Tibbitt,et al.  Hydrogels as extracellular matrix mimics for 3D cell culture. , 2009, Biotechnology and bioengineering.

[14]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[15]  S. Rizzi,et al.  Elucidating the role of matrix stiffness in 3D cell migration and remodeling. , 2011, Biophysical journal.

[16]  V. Verhasselt,et al.  Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. , 1997, Journal of immunology.

[17]  M. Shoichet,et al.  Synthesis of enzyme-degradable, peptide-cross-linked dextran hydrogels. , 2007, Bioconjugate chemistry.

[18]  Matthew Pilarz,et al.  Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells , 2007, Proceedings of the National Academy of Sciences.

[19]  Lin Yu,et al.  Injectable hydrogels as unique biomedical materials. , 2008, Chemical Society reviews.

[20]  Pedro L Granja,et al.  Injectable biodegradable polycaprolactone-sebacic acid gels for bone tissue engineering. , 2012, Tissue engineering. Part A.

[21]  J. Babensee,et al.  Differential functional effects of biomaterials on dendritic cell maturation. , 2012, Acta biomaterialia.

[22]  Jeffrey A. Hubbell,et al.  Polymeric biomaterials with degradation sites for proteases involved in cell migration , 1999 .

[23]  R. Soares,et al.  Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. , 2010, Biomacromolecules.

[24]  M. Nolte,et al.  Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.

[25]  H. Nisenbaum,et al.  A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer , 2012, Journal of immunotherapy.

[26]  Pedro L Granja,et al.  Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. , 2011, Biomaterials.

[27]  Ajazuddin,et al.  Alginate based hydrogel as a potential biopolymeric carrier for drug delivery and cell delivery systems: present status and applications. , 2012, Current drug delivery.

[28]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[29]  David J Mooney,et al.  Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. , 2007, Biomaterials.

[30]  M. Juliano,et al.  Enzymatic, physicochemical and biological properties of MMP-sensitive alginate hydrogels , 2013 .

[31]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[32]  Paola Petrini,et al.  Biofunctional chemically modified pectin for cell delivery , 2012 .

[33]  J. Babensee,et al.  Differential levels of dendritic cell maturation on different biomaterials used in combination products. , 2005, Journal of biomedical materials research. Part A.

[34]  D J Mooney,et al.  Regulating Bone Formation via Controlled Scaffold Degradation , 2003, Journal of dental research.

[35]  Marianne Ekman,et al.  Differentiation of human dendritic cells from monocytes in vitro , 1997, European journal of immunology.

[36]  M. Oliveira,et al.  Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation. , 2012, European cells & materials.

[37]  Kristi S Anseth,et al.  The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. , 2011, Biomaterials.

[38]  Matthias P Lutolf,et al.  The effect of matrix characteristics on fibroblast proliferation in 3D gels. , 2010, Biomaterials.

[39]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[40]  D J Mooney,et al.  Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis , 2007, Journal of thrombosis and haemostasis : JTH.